Biodyne Co., Ltd.
Research Biodyne Co., Ltd. (314930.KQ) on Bullrun: market cap KRW 180.40B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker314930.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyKRW
- Market capKRW 180.40B
- Financial periodQ2 2026
- RevenueKRW 587.32M
- Net income-KRW 323.04M
- Free cash flow-KRW 587.45M
- Gross margin35.4%
Valuation Snapshot
latest market cap is KRW 180.40B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 180.40B | n/a | n/a | n/a |
Dividend history
About Biodyne Co., Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biodyne Co., Ltd.'s market cap?
Biodyne Co., Ltd.'s market capitalization is KRW 180.40B.
What does Biodyne Co., Ltd. do?
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.